Klin Onkol 2015; 28(6): 470.
2015-12-15:Informace z České onkologické společnosti
2015-12-15:Informace z České onkologické společnosti
Klin Onkol 2015; 28(Suppl 3): 3.
Authors: Trněný Marek, Smolej Lukáš, Doubek Michael2015-10-15:Editorial
Authors: Trněný Marek, Smolej Lukáš, Doubek Michael2015-10-15:Editorial
Klin Onkol 2015; 28(Suppl 3): 6-15.
DOI: 10.14735/amko20153S6.
Keywords: chronic lymphocytic leukemia – biological markers – chromosome aberations – mutations – prognosis
Authors: Navrkalová Veronika, Kantorová Iva, Jarošová Marie, Pospíšilová Šárka2015-10-15:Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia – biological markers – chromosome aberations – mutations – prognosis
Authors: Navrkalová Veronika, Kantorová Iva, Jarošová Marie, Pospíšilová Šárka2015-10-15:Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia
Klin Onkol 2015; 28(Suppl 3): 16-21.
DOI: 10.14735/amko20153S16.
Keywords: chronic lymphocytic leukemia – minimal residual disease – prognostic factors – fl ow cytometry – progression-free survival
Authors: Doubek Michael2015-10-15:Significance of Minimal Residual Disease in Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia – minimal residual disease – prognostic factors – fl ow cytometry – progression-free survival
Authors: Doubek Michael2015-10-15:Significance of Minimal Residual Disease in Chronic Lymphocytic Leukemia
Klin Onkol 2015; 28(Suppl 3): 22-29.
DOI: 10.14735/amko20153S22.
Keywords: monoclonal antibody – rituximab – ofatumumab – alemtuzumab – obinutuzumab
Authors: Obrtlíková Petra, Urbanová Renata2015-10-15:Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015
Keywords: monoclonal antibody – rituximab – ofatumumab – alemtuzumab – obinutuzumab
Authors: Obrtlíková Petra, Urbanová Renata2015-10-15:Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015
Klin Onkol 2015; 28(Suppl 3): 30-38.
DOI: 10.14735/amko20153S30.
Keywords: chronic lymphocytic leukemia – comorbidity – geriatric assessment – obinutuzumab – rituximab – ofatumumab – ibrutinib – idelalisib
Authors: Smolej Lukáš2015-10-15:Therapeutic Options for „Slow-go“ Patients with Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia – comorbidity – geriatric assessment – obinutuzumab – rituximab – ofatumumab – ibrutinib – idelalisib
Authors: Smolej Lukáš2015-10-15:Therapeutic Options for „Slow-go“ Patients with Chronic Lymphocytic Leukemia
Klin Onkol 2015; 28(Suppl 3): 39-44.
DOI: 10.14735/amko20153S39.
Keywords: chronic lymphocytic leukemia – risk factors – deletion 17p – TP53 – transplantation
Authors: Lysák Daniel, Schwarz Jiří2015-10-15:Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations
Keywords: chronic lymphocytic leukemia – risk factors – deletion 17p – TP53 – transplantation
Authors: Lysák Daniel, Schwarz Jiří2015-10-15:Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations
Klin Onkol 2015; 28(Suppl 3): 45-49.
DOI: 10.14735/amko20153S45.
Keywords: chronic lymphocytic leukemia – ibrutinib – idelalisib – rituximab – ABT- 199
Authors: Špaček Jiří2015-10-15:Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future
Keywords: chronic lymphocytic leukemia – ibrutinib – idelalisib – rituximab – ABT- 199
Authors: Špaček Jiří2015-10-15:Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future
Klin Onkol 2015; 28(Suppl 3): 50-54.
DOI: 10.14735/amko20153S50.
Keywords: chronic lymphocytic leukemia – supportive care – infectious complications
Authors: Brejcha Martin2015-10-15:News in the Supportive Care of Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia – supportive care – infectious complications
Authors: Brejcha Martin2015-10-15:News in the Supportive Care of Chronic Lymphocytic Leukemia
Klin Onkol 2015; 28(Suppl 3): 55-63.
DOI: 10.14735/amko20153S55.
Keywords: lymphoma – classification – chemotherapy − targeted therapy
Authors: Trněný Marek, Klener jr Pavel, Pytlík Robert2015-10-15:Malignant Lymphomas – Past, Present and Future
Keywords: lymphoma – classification – chemotherapy − targeted therapy
Authors: Trněný Marek, Klener jr Pavel, Pytlík Robert2015-10-15:Malignant Lymphomas – Past, Present and Future
Klin Onkol 2015; 28(Suppl 3): 64-72.
DOI: 10.14735/amko20153S64.
Keywords: diffuse large B- cell lymphoma – gene expression profiling – signal transduction pathways – treatment
Authors: Pytlík Robert, Trněný Marek2015-10-15:Diffuse Large B- cell Lymphoma – Modern Diagnostics and Molecularly Targeted Treatment
Keywords: diffuse large B- cell lymphoma – gene expression profiling – signal transduction pathways – treatment
Authors: Pytlík Robert, Trněný Marek2015-10-15:Diffuse Large B- cell Lymphoma – Modern Diagnostics and Molecularly Targeted Treatment
Klin Onkol 2015; 28(Suppl 3): 73-79.
DOI: 10.14735/amko20153S73.
Keywords: follicular lymphoma – diagnosis – treatment
Authors: Benešová Kateřina, Trněný Marek2015-10-15:Follicular Lymphoma
Keywords: follicular lymphoma – diagnosis – treatment
Authors: Benešová Kateřina, Trněný Marek2015-10-15:Follicular Lymphoma
Klin Onkol 2015; 28(Suppl 3): 80-86.
DOI: 10.14735/amko20153S80.
Keywords: mantle cell lymphoma – minimal residual disease – autologous transplantation
Authors: Klener jr Pavel, Trněný Marek2015-10-15:Mantle Cell Lymphoma – Cutting- edge Diagnostics and Treatment Approaches
Keywords: mantle cell lymphoma – minimal residual disease – autologous transplantation
Authors: Klener jr Pavel, Trněný Marek2015-10-15:Mantle Cell Lymphoma – Cutting- edge Diagnostics and Treatment Approaches
Klin Onkol 2015; 28(Suppl 3): 87-94.
DOI: 10.14735/amko20153S87.
Keywords: Hodgkin’s lymphoma – induction chemotherapy – salvage therapy – combined modality therapy – hematopoietic stem cell transplantation – positron-emission tomography – brentuximab vedotin – nivolumab
Authors: Kořen Jan, Trněný Marek2015-10-15:Hodgkin´s Lymhoma – the Treatment Aproaches Development and Current Trends
Keywords: Hodgkin’s lymphoma – induction chemotherapy – salvage therapy – combined modality therapy – hematopoietic stem cell transplantation – positron-emission tomography – brentuximab vedotin – nivolumab
Authors: Kořen Jan, Trněný Marek2015-10-15:Hodgkin´s Lymhoma – the Treatment Aproaches Development and Current Trends
Klin Onkol 2015; 28(Suppl 3): 95-104.
DOI: 10.14735/amko20153S95.
Keywords: refractory/ relapsed lymphoma – Hodgkin’s lymphoma – diffuse large B- cell lymphoma – follicular lymphoma – T-cell non-Hodgkin lymphoma – autologous stem cell transplantation – allogeneic hematopoietic stem cell transplantation
Authors: Pohlreich David, Vacková Blanka, Pytlík Robert, Trnková Marie, Trněný Marek2015-10-15:Salvage Treatment and the Role of Transplantation in Lymphomas
Keywords: refractory/ relapsed lymphoma – Hodgkin’s lymphoma – diffuse large B- cell lymphoma – follicular lymphoma – T-cell non-Hodgkin lymphoma – autologous stem cell transplantation – allogeneic hematopoietic stem cell transplantation
Authors: Pohlreich David, Vacková Blanka, Pytlík Robert, Trnková Marie, Trněný Marek2015-10-15:Salvage Treatment and the Role of Transplantation in Lymphomas
